Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller

Science Translational Medicine

Volumn 9, Issue 373, 2017, Pages

  Freund, Natalia T ^a   Wang, Haoqing ^b   Scharf, Louise ^b,i   Nogueira, Lilian ^a   Horwitz, Joshua A ^a   Bar On, Yotam ^a   Golijanin, Jovana ^a   Sievers, Stuart A ^b,j   Sok, Devin ^c   Cai, Hui ^d   Lorenzi, Julio C Cesar ^a   Halper Stromberg, Ariel ^a   Toth, Ildiko ^e   Piechocka Trocha, Alicja ^e   Gristick, Harry B ^b   Van Gils, Marit J ^f   Sanders, Rogier W ^f   Wang, Lai Xi ^d   Seaman, Michael S ^g   Burton, Dennis R ^c,e   Gazumyan, Anna ^a   Walker, Bruce D ^e,h   West, Anthony P ^b   Bjorkman, Pamela J ^b   Nussenzweig, Michel C ^a,h   more..

^a ROCKEFELLER UNIVERSITY   (United States)

^b California Institute of Technology   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d University of Maryland   (United States)

^e HARVARD UNIVERSITY   (United States)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g HARVARD MEDICAL SCHOOL   (United States)

^h HOWARD HUGHES MEDICAL INSTITUTE   (United States)

ⁱ 23andMe ^*  (United States)

^j Kite Pharma   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; HLA B57 ANTIGEN; NEUTRALIZING ANTIBODY; EPITOPE; HLA B ANTIGEN; HLA-B57 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CRYSTALLOGRAPHY; ELECTRON MICROSCOPY; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION CONTROL; MOUSE; NONHUMAN; VIREMIA; VIRUS ENVELOPE; VIRUS GENOME; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS STRAIN; ANIMAL; B LYMPHOCYTE; COHORT ANALYSIS; HEK293 CELL LINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; SERODIAGNOSIS; TRANSGENIC MOUSE; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTIBODIES, NEUTRALIZING; B-LYMPHOCYTES; COHORT STUDIES; CRYSTALLOGRAPHY, X-RAY; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; EPITOPES; HEK293 CELLS; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HLA-B27 ANTIGEN; HUMANS; MICE; MICE, TRANSGENIC; NEUTRALIZATION TESTS; VIRAL LOAD; VIREMIA;

EID: 85010469649     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aal2144     Document Type: Article

References (104)

1. D. R. Burton, J. R. Mascola, Antibody responses to envelope glycoproteins in HIV-1 infection. Nat. Immunol. 16, 571-576 (2015).
2. F. Klein, H. Mouquet, P. Dosenovic, J. F. Scheid, L. Scharf, M. C. Nussenzweig, Antibodies in HIV-1 vaccine development and therapy. Science 341, 1199-1204 (2013).
3. A. P. West Jr., L. Scharf, J. F. Scheid, F. Klein, P. J. Bjorkman, M. C. Nussenzweig, Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell 156, 633-648 (2014).
4. E. Landais, X. Huang, C. Havenar-Daughton, B. Murrell, M. A. Price, L. Wickramasinghe, A. Ramos, C. B. Bian, M. Simek, S. Allen, E. Karita, W. Kilembe, S. Lakhi, M. Inambao, A. Kamali, E. J. Sanders, O. Anzala, V. Edward, L.-G. Bekker, J. Tang, J. Gilmour, S. L. Kosakovsky-Pond, P. Phung, T. Wrin, S. Crotty, A. Godzik, P. Poignard, Broadly neutralizing antibody responses in a large longitudinal sub-saharan HIV primary infection cohort. PLOS Pathog. 12, e1005369 (2016).
5. C. K. Wibmer, J. N. Bhiman, E. S. Gray, N. Tumba, S. S. Abdool Karim, C. Williamson, L. Morris, P. L. Moore, Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. PLOS Pathog. 9, e1003738 (2013).
6. H.-X. Liao, R. Lynch, T. Zhou, F. Gao, S. M. Alam, S. D. Boyd, A. Z. Fire, K. M. Roskin, C. A. Schramm, Z. Zhang, J. Zhu, L. Shapiro; NISC Comparative Sequencing Program, J. C. Mullikin, S. Gnanakaran, P. Hraber, K. Wiehe, G. Kelsoe, G. Yang, S.-M. Xia, D. C. Montefiori, R. Parks, K. E. Lloyd, R. M. Scearce, K. A. Soderberg, M. Cohen, G. Kamanga, M. K. Louder, L. M. Tran, Y. Chen, F. Cai, S. Chen, S. Moquin, X. Du, M. G. Joyce, S. Srivatsan, B. Zhang, A. Zheng, G. M. Shaw, B. H. Hahn, T. B. Kepler, B. T. M. Korber, P. D. Kwong, J. R. Mascola, B. F. Haynes, Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496, 469-476 (2013).
7. N. A. Doria-Rose, C. A. Schramm, J. Gorman, P. L. Moore, J. N. Bhiman, B. J. DeKosky, M. J. Ernandes, I. S. Georgiev, H. J. Kim, M. Pancera, R. P. Staupe, H. R. Altae-Tran, R. T. Bailer, E. T. Crooks, A. Cupo, A. Druz, N. J. Garrett, K. H. Hoi, R. Kong, M. K. Louder, N. S. Longo, K. McKee, M. Nonyane, S. O'Dell, R. S. Roark, R. S. Rudicell, S. D. Schmidt, D. J. Sheward, C. Soto, C. K. Wibmer, Y. Yang, Z. Zhang; NISC Comparative Sequencing Program, J. C. Mullikin, J. M. Binley, R. W. Sanders, I. A. Wilson, J. P. Moore, A. B. Ward, G. Georgiou, C. Williamson, S. S. Abdool Karim, L. Morris, P. D. Kwong, L. Shapiro, J. R. Mascola, Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature 509, 55-62 (2014).
8. M. Bonsignori, T. Zhou, Z. Sheng, L. Chen, F. Gao, M. G. Joyce, G. Ozorowski, G.-Y. Chuang, C. A. Schramm, K. Wiehe, S. M. Alam, T. Bradley, M. A. Gladden, K.-K. Hwang, S. Iyengar, A. Kumar, X. Lu, K. Luo, M. C. Mangiapani, R. J. Parks, H. Song, P. Acharya, R. T. Bailer, A. Cao, A. Druz, I. S. Georgiev, Y. D. Kwon, M. K. Louder, B. Zhang, A. Zheng, B. J. Hill, R. Kong, C. Soto; NSCI Comparative Sequencing Program, J. C. Mullikin, D. C. Douek, D. C. Montefiori, M. A. Moody, G. M. Shaw, B. H. Hahn, G. Kelsoe, P. T. Hraber, B. T. Korber, S. D. Boyd, A. Z. Fire, T. B. Kepler, L. Shapiro, A. B. Ward, J. R. Mascola, H.-X. Liao, P. D. Kwong, B. F. Haynes, Maturation pathway from germline to broad HIV-1 neutralizer of a CD4-mimic antibody. Cell 165, 449-463 (2016).
9. D. T. MacLeod, N. M. Choi, B. Briney, F. Garces, L. S. Ver, E. Landais, B. Murrell, T. Wrin, W. Kilembe, C.-H. Liang, A. Ramos, C. B. Bian, L. Wickramasinghe, L. Kong, K. Eren, C.-Y. Wu, C.-H. Wong; The IAVI Protocol C Investigators; The IAVI African HIV Research Network, S. L. Kosakovsky Pond, I. A. Wilson, D. R. Burton, P. Poignard, Early antibody lineage diversification and independent limb maturation lead to broad HIV-1 neutralization targeting the Env high-mannose patch. Immunity 44, 1215-1226 (2016).
10. K. J. Bar, C.-y. Tsao, S. S. Iyer, J. M. Decker, Y. Yang, M. Bonsignori, X. Chen, K.-K. Hwang, D. C. Montefiori, H.-X. Liao, P. Hraber, W. Fischer, H. Li, S. Wang, S. Sterrett, B. F. Keele, V. V. Ganusov, A. S. Perelson, B. T. Korber, I. Georgiev, J. S. McLellan, J. W. Pavlicek, F. Gao, B. F. Haynes, B. H. Hahn, P. D. Kwong, G. M. Shaw, Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLOS Pathog. 8, e1002721 (2012).
11. D. N. Sather, S. Carbonetti, D. Malherbe, F. Pissani, A. B. Stuart, A. J. Hessell, M. D. Gray, I. Mikell, S. A. Kalams, N. L. Haigwood, L. Stamatatos, Emergence of broadly neutralizing antibodies and viral co-evolution in two subjects during the early stages of infection with the human immunodeficiency virus type 1. J. Virol. 10.1128/JVI.01816-14 (2014).
12. J. N. Bhiman, C. Anthony, N. A. Doria-Rose, O. Karimanzira, C. A. Schramm, T. Khoza, D. Kitchin, G. Botha, J. Gorman, N. J. Garrett, S. S. Abdool Karim, L. Shapiro, C. Williamson, P. D. Kwong, J. R. Mascola, L. Morris, P. L. Moore, Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies. Nat. Med. 21, 1332-1336 (2015).
13. M. Bonsignori, S. M. Alam, H.-X. Liao, L. Verkoczy, G. D. Tomaras, B. F. Haynes, M. A. Moody, HIV-1 antibodies from infection and vaccination: Insights for guiding vaccine design. Trends Microbiol. 20, 532-539 (2012).
14. F. Klein, R. Diskin, J. F. Scheid, C. Gaebler, H. Mouquet, I. S. Georgiev, M. Pancera, T. Zhou, R.-B. Incesu, B. Z. Fu, P. N. P. Gnanapragasam, T. Y. Oliveira, M. S. Seaman, P. D. Kwong, P. J. Bjorkman, M. C. Nussenzweig, Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell 153, 126-138 (2013).
15. P. L. Moore, E. S. Gray, C. K. Wibmer, J. N. Bhiman, M. Nonyane, D. J. Sheward, T. Hermanus, S. Bajimaya, N. L. Tumba, M.-R. Abrahams, B. E. Lambson, N. Ranchobe, L. Ping, N. Ngandu, Q. Abdool Karim, S. S. Abdool Karim, R. I. Swanstrom, M. S. Seaman, C. Williamson, L. Morris, Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape. Nat. Med. 18, 1688-1692 (2012).
16. H. Mouquet, J. F. Scheid, M. J. Zoller, M. Krogsgaard, R. G. Ott, S. Shukair, M. N. Artyomov, J. Pietzsch, M. Connors, F. Pereyra, B. D. Walker, D. D. Ho, P. C. Wilson, M. S. Seaman, H. N. Eisen, A. K. Chakraborty, T. J. Hope, J. V. Ravetch, H. Wardemann, M. C. Nussenzweig, Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 467, 591-595 (2010).
17. J. F. Scheid, H. Mouquet, N. Feldhahn, M. S. Seaman, K. Velinzon, J. Pietzsch, R. G. Ott, R. M. Anthony, H. Zebroski, A. Hurley, A. Phogat, B. Chakrabarti, Y. Li, M. Connors, F. Pereyra, B. D. Walker, H. Wardemann, D. Ho, R. T. Wyatt, J. R. Mascola, J. V. Ravetch, M. C. Nussenzweig, Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458, 636-640 (2009).
18. D. Mendoza, C. Royce, L. E. Ruff, D. R. Ambrozak, M. F. Quigley, T. Dang, V. Venturi, D. A. Price, D. C. Douek, S. A. Migueles, M. Connors, HLA B∗5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells. J. Virol. 86, 4014-4018 (2012).
19. T. Miura, M. A. Brockman, A. Schneidewind, M. Lobritz, F. Pereyra, A. Rathod, B. L. Block, Z. L. Brumme, C. J. Brumme, B. Baker, A. C. Rothchild, B. Li, A. Trocha, E. Cutrell, N. Frahm, C. Brander, I. Toth, E. J. Arts, T. M. Allen, B. D. Walker, HLA-B57/B∗5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte recognition. J. Virol. 83, 2743-2755 (2009).
20. J. F. Scheid, H. Mouquet, N. Feldhahn, B. D. Walker, F. Pereyra, E. Cutrell, M. S. Seaman, J. R. Mascola, R. T. Wyatt, H. Wardemann, M. C. Nussenzweig, A method for identification of HIV gp140 binding memory B cells in human blood. J. Immunol. Methods 343, 65-67 (2009).
21. J. F. Scheid, H. Mouquet, B. Ueberheide, R. Diskin, F. Klein, T. Y. K. Oliveira, J. Pietzsch, D. Fenyo, A. Abadir, K. Velinzon, A. Hurley, S. Myung, F. Boulad, P. Poignard, D. R. Burton, F. Pereyra, D. D. Ho, B. D. Walker, M. S. Seaman, P. J. Bjorkman, B. T. Chait, M. C. Nussenzweig, Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333, 1633-1637 (2011).
22. D. Sok, M. J. van Gils, M. Pauthner, J.-P. Julien, K. L. Saye-Francisco, J. Hsueh, B. Briney, J. H. Lee, K. M. Le, P. S. Lee, Y. Hua, M. S. Seaman, J. P. Moore, A. B. Ward, I. A. Wilson, R. W. Sanders, D. R. Burton, Recombinant HIV envelope trimer selects for quaternarydependent antibodies targeting the trimer apex. Proc. Natl. Acad. Sci. U.S.A. 111, 17624-17629 (2014).
23. B. Dey, K. Svehla, L. Xu, D. Wycuff, T. Zhou, G. Voss, A. Phogat, B. K. Chakrabarti, Y. Li, G. Shaw, P. D. Kwong, G. J. Nabel, J. R. Mascola, R. T. Wyatt, Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site. PLOS Pathog. 5, e1000445 (2009).
24. X. Yang, M. Farzan, R. Wyatt, J. Sodroski, Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 74, 5716-5725 (2000).
25. J. M. Kovacs, J. P. Nkolola, H. Peng, A. Cheung, J. Perry, C. A. Miller, M. S. Seaman, D. H. Barouch, B. Chen, HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120. Proc. Natl. Acad. Sci. U.S.A. 109, 12111-12116 (2012).
26. R. W. Sanders, R. Derking, A. Cupo, J.-P. Julien, A. Yasmeen, N. de Val, H. J. Kim, C. Blattner, A. T. de la Peña, J. Korzun, M. Golabek, K. de Los Reyes, T. J. Ketas, M. J. van Gils, C. R. King, I. A. Wilson, A. B. Ward, P. J. Klasse, J. P. Moore, A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLOS Pathog. 9, e1003618 (2013).
27. H. Mouquet, L. Scharf, Z. Euler, Y. Liu, C. Eden, J. F. Scheid, A. Halper-Stromberg, P. N. P. Gnanapragasam, D. I. R. Spencer, M. S. Seaman, H. Schuitemaker, T. Feizi, M. C. Nussenzweig, P. J. Bjorkman, Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc. Natl. Acad. Sci. U.S.A. 109, E3268-E3277 (2012).
28. L. M. Walker, M. Huber, K. J. Doores, E. Falkowska, R. Pejchal, J.-P. Julien, S.-K. Wang, A. Ramos, P.-Y. Chan-Hui, M. Moyle, J. L. Mitcham, P. W. Hammond, O. A. Olsen, P. Phung, S. Fling, C.-H. Wong, S. Phogat, T. Wrin, M. D. Simek; Protocol G. Principal Investigators, W. C. Koff, I. A. Wilson, D. R. Burton, P. Poignard, Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466-470 (2011).
29. M. Pancera, T. Zhou, A. Druz, I. S. Georgiev, C. Soto, J. Gorman, J. Huang, P. Acharya, G.-Y. Chuang, G. Ofek, G. B. E. Stewart-Jones, J. Stuckey, R. T. Bailer, M. G. Joyce, M. K. Louder, N. Tumba, Y. Yang, B. Zhang, M. S. Cohen, B. F. Haynes, J. R. Mascola, L. Morris, J. B. Munro, S. C. Blanchard, W. Mothes, M. Connors, P. D. Kwong, Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature 514, 455-461 (2014).
30. N. T. Freund, J. A. Horwitz, L. Nogueira, S. A. Sievers, L. Scharf, J. F. Scheid, A. Gazumyan, C. Liu, K. Velinzon, A. Goldenthal, R. W. Sanders, J. P. Moore, P. J. Bjorkman, M. S. Seaman, B. D. Walker, F. Klein, M. C. Nussenzweig, A new glycan-dependent CD4-binding site neutralizing antibody exerts pressure on HIV-1 in vivo. PLOS Pathog. 11, e1005238 (2015).
31. F. Garces, D. Sok, L. Kong, R. McBride, H. J. Kim, K. F. Saye-Francisco, J.-P. Julien, Y. Hua, A. Cupo, J. P. Moore, J. C. Paulson, A. B. Ward, D. R. Burton, I. A. Wilson, Structural evolution of glycan recognition by a family of potent HIV antibodies. Cell 159, 69-79 (2014).
32. J. F. Salazar-Gonzalez, E. Bailes, K. T. Pham, M. G. Salazar, M. B. Guffey, B. F. Keele, C. A. Derdeyn, P. Farmer, E. Hunter, S. Allen, O. Manigart, J. Mulenga, J. A. Anderson, R. Swanstrom, B. F. Haynes, G. S. Athreya, B. T. M. Korber, P. M. Sharp, G. M. Shaw, B. H. Hahn, Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 82, 3952-3970 (2008).
33. L. Alexander, E. Weiskopf, T. C. Greenough, N. C. Gaddis, M. R. Auerbach, M. H. Malim, S. J. O'Brien, B. D. Walker, J. L. Sullivan, R. C. Desrosiers, Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J. Virol. 74, 4361-4376 (2000).
34. P. L. Moore, E. T. Crooks, L. Porter, P. Zhu, C. S. Cayanan, H. Grise, P. Corcoran, M. B. Zwick, M. Franti, L. Morris, K. H. Roux, D. R. Burton, J. M. Binley, Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J. Virol. 80, 2515-2528 (2006).
35. J. A. Horwitz, A. Halper-Stromberg, H. Mouquet, A. D. Gitlin, A. Tretiakova, T. R. Eisenreich, M. Malbec, S. Gravemann, E. Billerbeck, M. Dorner, H. Büning, O. Schwartz, E. Knops, R. Kaiser, M. S. Seaman, J. M. Wilson, C. M. Rice, A. Ploss, P. J. Bjorkman, F. Klein, M. C. Nussenzweig, HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proc. Natl. Acad. Sci. U.S.A. 110, 16538-16543 (2013).
36. J. L. Kirchherr, X. Lu, W. Kasongo, V. Chalwe, L. Mwananyanda, R. M. Musonda, S.-M. Xia, R. M. Scearce, H.-X. Liao, D. C. Montefiori, B. F. Haynes, F. Gao, High throughput functional analysis of HIV-1 env genes without cloning. J. Virol. Methods 143, 104-111 (2007).
37. A. B. van 't Wout, H. Schuitemaker, N. A. Kootstra, Isolation and propagation of HIV-1 on peripheral blood mononuclear cells. Nat. Protoc. 3, 363-370 (2008).
38. F. Klein, A. Halper-Stromberg, J. A. Horwitz, H. Gruell, J. F. Scheid, S. Bournazos, H. Mouquet, L. A. Spatz, R. Diskin, A. Abadir, T. Zang, M. Dorner, E. Billerbeck, R. N. Labitt, C. Gaebler, P. M. Marcovecchio, R.-B. Incesu, T. R. Eisenreich, P. D. Bieniasz, M. S. Seaman, P. J. Bjorkman, J. V. Ravetch, A. Ploss, M. C. Nussenzweig, HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature 492, 118-122 (2012).
39. T. Zhou, I. Georgiev, X. Wu, Z.-Y. Yang, K. Dai, A. Finzi, Y. D. Kwon, J. F. Scheid, W. Shi, L. Xu, Y. Yang, J. Zhu, M. C. Nussenzweig, J. Sodroski, L. Shapiro, G. J. Nabel, J. R. Mascola, P. D. Kwong, Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329, 811-817 (2010).
40. A. P. West Jr., R. Diskin, M. C. Nussenzweig, P. J. Bjorkman, Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120. Proc. Natl. Acad. Sci. U.S.A. 109, E2083-E2090 (2012).
41. H. B. Gristick, L. von Boehmer, A. P. West Jr., M. Schamber, A. Gazumyan, J. Golijanin, M. S. Seaman, G. Fatkenheuer, F. Klein, M. C. Nussenzweig, P. J. Bjorkman, Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site. Nat. Struct. Mol. Biol. 23, 906-915 (2016).
42. A. B. Ward, I. A. Wilson, Insights into the trimeric HIV-1 envelope glycoprotein structure. Trends Biochem. Sci. 40, 101-107 (2015).
43. P. D. Adams, P. V. Afonine, G. Bunkóczi, V. B. Chen, I. W. Davis, N. Echols, J. J. Headd, L.-W. Hung, G. J. Kapral, R. W. Grosse-Kunstleve, A. J. McCoy, N. W. Moriarty, R. Oeffner, R. J. Read, D. C. Richardson, J. S. Richardson, T. C. Terwilliger, P. H. Zwart, PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221 (2010).
44. R. Diskin, J. F. Scheid, P. M. Marcovecchio, A. P. West Jr., F. Klein, H. Gao, P. N. P. Gnanapragasam, A. Abadir, M. S. Seaman, M. C. Nussenzweig, P. J. Bjorkman, Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science 334, 1289-1293 (2011).
45. T. Zhou, R. M. Lynch, L. Chen, P. Acharya, X. Wu, N. A. Doria-Rose, M. G. Joyce, D. Lingwood, C. Soto, R. T. Bailer, M. J. Ernandes, R. Kong, N. S. Longo, M. K. Louder, K. McKee, S. O'Dell, S. D. Schmidt, L. Tran, Z. Yang, A. Druz, T. S. Luongo, S. Moquin, S. Srivatsan, Y. Yang, B. Zhang, A. Zheng, M. Pancera, T. Kirys, I. S. Georgiev, T. Gindin, H.-P. Peng, A.-S. Yang; NISC Comparative Sequencing Program, J. C. Mullikin, M. D. Gray, L. Stamatatos, D. R. Burton, W. C. Koff, M. S. Cohen, B. F. Haynes, J. P. Casazza, M. Connors, D. Corti, A. Lanzavecchia, Q. J. Sattentau, R. A. Weiss, A. P. West Jr., P. J. Bjorkman, J. F. Scheid, M. C. Nussenzweig, L. Shapiro, J. R. Mascola, P. D. Kwong, Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors. Cell 16, 1280-1292 (2015).
46. K. Ariyoshi, E. Harwood, R. Chiengsong-Popov, J. Weber, Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies? Lancet 340, 1257-1258 (1992).
47. D. D. Richman, T. Wrin, S. J. Little, C. J. Petropoulos, Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. U.S.A. 100, 4144-4149 (2003).
48. X. Wei, J. M. Decker, S. Wang, H. Hui, J. C. Kappes, X. Wu, J. F. Salazar-Gonzalez, M. G. Salazar, J. M. Kilby, M. S. Saag, N. L. Komarova, M. A. Nowak, B. H. Hahn, P. D. Kwong, G. M. Shaw, Antibody neutralization and escape by HIV-1. Nature 422, 307-312 (2003).
49. P. L. Moore, D. Sheward, M. Nonyane, N. Ranchobe, T. Hermanus, E. S. Gray, S. S. Abdool Karim, C. Williamson, L. Morris, Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies. J. Virol. 87, 4882-4894 (2013).
50. L. E. McCoy, M. J. van Gils, G. Ozorowski, T. Messmer, B. Briney, J. E. Voss, D. W. Kulp, M. S. Macauley, D. Sok, M. Pauthner, S. Menis, C. A. Cottrell, J. L. Torres, J. Hsueh, W. R. Schief, I. A. Wilson, A. B. Ward, R. W. Sanders, D. R. Burton, Holes in the glycan shield of the native HIV envelope are a target of trimer-elicited neutralizing antibodies. Cell Rep. 16, 2327-2338 (2016).
51. P. L. Moore, E. S. Gray, L. Morris, Specificity of the autologous neutralizing antibody response. Curr. Opin. HIV AIDS 4, 358-363 (2009).
52. F. Gao, M. Bonsignori, H.-X. Liao, A. Kumar, S.-M. Xia, X. Lu, F. Cai, K.-K. Hwang, H. Song, T. Zhou, R. M. Lynch, S. M. Alam, M. A. Moody, G. Ferrari, M. Berrong, G. Kelsoe, G. M. Shaw, B. H. Hahn, D. C. Montefiori, G. Kamanga, M. S. Cohen, P. Hraber, P. D. Kwong, B. T. Korber, J. R. Mascola, T. B. Kepler, B. F. Haynes, Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. Cell 158, 481-491 (2014).
53. L. Kong, B. Ju, Y. Chen, L. He, L. Ren, J. Liu, K. Hong, B. Su, Z. Wang, G. Ozorowski, X. Ji, Y. Hua, Y. Chen, M. C. Deller, Y. Hao, Y. Feng, F. Garces, R. Wilson, K. Dai, S. O'Dell, K. McKee, J. R. Mascola, A. B. Ward, R. T. Wyatt, Y. Li, I. A. Wilson, J. Zhu, Y. Shao, Key gp120 glycans pose roadblocks to the rapid development of VRC01-class antibodies in an HIV-1-infected chinese donor. Immunity 44, 939-950 (2016).
54. J. Learmont, B. Tindall, L. Evans, A. Cunningham, P. Cunningham, J. Wells, R. Penny, J. Kaldor, D. A. Cooper, Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 340, 863-867 (1992).
55. I. P. Keet, A. Krol, M. R. Klein, P. Veugelers, J. de Wit, M. Roos, M. Koot, J. Goudsmit, F. Miedema, R. A. Coutinho, Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts. J. Infect. Dis. 169, 1236-1243 (1994).
56. Y. Cao, L. Qin, L. Zhang, J. Safrit, D. D. Ho, Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332, 201-208 (1995).
57. R. H. Gray, M. J. Wawer, R. Brookmeyer, N. K. Sewankambo, D. Serwadda, F. Wabwire-Mangen, T. Lutalo, X. Li, T. vanCott, T. C. Quinn; Rakai Project Team, Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357, 1149-1153 (2001).
58. J. V. Giorgi, R. H. Lyles, J. L. Matud, T. E. Yamashita, J. W. Mellors, L. E. Hultin, B. D. Jamieson, J. B. Margolick, C. R. Rinaldo Jr., J. P. Phair, R. Detels; Multicenter AIDS Cohort Study, Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J. Acquir. Immune Defic. Syndr. 29, 346-355 (2002).
59. S. A. Migueles, M. S. Sabbaghian, W. L. Shupert, M. P. Bettinotti, F. M. Marincola, L. Martino, C. W. Hallahan, S. M. Selig, D. Schwartz, J. Sullivan, M. Connors, HLA B∗5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. U.S.A. 97, 2709-2714 (2000).
60. F. Pereyra, M. M. Addo, D. E. Kaufmann, Y. Liu, T. Miura, A. Rathod, B. Baker, A. Trocha, R. Rosenberg, E. Mackey, P. Ueda, Z. Lu, D. Cohen, T. Wrin, C. J. Petropoulos, E. S. Rosenberg, B. D. Walker, Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 197, 563-571 (2008).
61. F. Pereyra, S. Palmer, T. Miura, B. L. Block, A. Wiegand, A. C. Rothchild, B. Baker, R. Rosenberg, E. Cutrell, M. S. Seaman, J. M. Coffin, B. D. Walker, Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. J. Infect. Dis. 200, 984-990 (2009).
62. J. R. Bailey, K. G. Lassen, H.-C. Yang, T. C. Quinn, S. C. Ray, J. N. Blankson, R. F. Siliciano, Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy. J. Virol. 80, 4758-4770 (2006).
63. N. A. Doria-Rose, R. M. Klein, M. G. Daniels, S. O'Dell, M. Nason, A. Lapedes, T. Bhattacharya, S. A. Migueles, R. T. Wyatt, B. T. Korber, J. R. Mascola, M. Connors, Breadth of human immunodeficiency virus-specific neutralizing activity in sera: Clustering analysis and association with clinical variables. J. Virol. 84, 1631-1636 (2010).
64. Z. Euler, M. J. van Gils, E. M. Bunnik, P. Phung, B. Schweighardt, T. Wrin, H. Schuitemaker, Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression. J. Infect. Dis. 201, 1045-1053 (2010).
65. M. J. van Gils, Z. Euler, B. Schweighardt, T. Wrin, H. Schuitemaker, Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression. AIDS 23, 2405-2414 (2009).
66. P. Rusert, R. D. Kouyos, C. Kadelka, H. Ebner, M. Schanz, M. Huber, D. L. Braun, N. Hozé, A. Scherrer, C. Magnus, J. Weber, T. Uhr, V. Cippa, C. W. Thorball, H. Kuster, M. Cavassini, E. Bernasconi, M. Hoffmann, A. Calmy, M. Battegay, A. Rauch, S. Yerly, V. Aubert, T. Klimkait, J. Böni, J. Fellay, R. R. Regoes, H. F. Günthard, A. Trkola; Swiss HIV Cohort Study, Determinants of HIV-1 broadly neutralizing antibody induction. Nat. Med. 22, 1260-1267 (2016).
67. F. Klein, C. Gaebler, H. Mouquet, D. N. Sather, C. Lehmann, J. F. Scheid, Z. Kraft, Y. Liu, J. Pietzsch, A. Hurley, P. Poignard, T. Feizi, L. Morris, B. D. Walker, G. Fätkenheuer, M. S. Seaman, L. Stamatatos, M. C. Nussenzweig, Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein. J. Exp. Med. 209, 1469-1479 (2012).
68. L. M. Walker, M. D. Simek, F. Priddy, J. S. Gach, D. Wagner, M. B. Zwick, S. K. Phogat, P. Poignard, D. R. Burton, A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLOS Pathog. 6, e1001028 (2010).
69. I. S. Georgiev, N. A. Doria-Rose, T. Zhou, Y. D. Kwon, R. P. Staupe, S. Moquin, G.-Y. Chuang, M. K. Louder, S. D. Schmidt, H. R. Altae-Tran, R. T. Bailer, K. McKee, M. Nason, S. O'Dell, G. Ofek, M. Pancera, S. Srivatsan, L. Shapiro, M. Connors, S. A. Migueles, L. Morris, Y. Nishimura, M. A. Martin, J. R. Mascola, P. D. Kwong, Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization. Science 340, 751-756 (2013).
70. R. A. Weiss, P. R. Clapham, J. N. Weber, A. G. Dalgleish, L. A. Lasky, P. W. Berman, Variable and conserved neutralization antigens of human immunodeficiency virus. Nature 324, 572-575 (1986).
71. C. A. Derdeyn, P. L. Moore, L. Morris, Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection. Curr. Opin. HIV AIDS 9, 210-216 (2014).
72. M. Mahalanabis, P. Jayaraman, T. Miura, F. Pereyra, E. M. Chester, B. Richardson, B. Walker, N. L. Haigwood, Continuous viral escape and selection by autologous neutralizing antibodies in drug-naïve human immunodeficiency virus controllers. J. Virol. 83, 662-672 (2009).
73. M. A. Moody, F. Gao, T. C. Gurley, J. D. Amos, A. Kumar, B. Hora, D. J. Marshall, J. F. Whitesides, S.-M. Xia, R. Parks, K. E. Lloyd, K.-K. Hwang, X. Lu, M. Bonsignori, A. Finzi, N. A. Vandergrift, S. M. Alam, G. Ferrari, X. Shen, G. D. Tomaras, G. Kamanga, M. S. Cohen, N. E. Sam, S. Kapiga, E. S. Gray, N. L. Tumba, L. Morris, S. Zolla-Pazner, M. K. Gorny, J. R. Mascola, B. H. Hahn, G. M. Shaw, J. G. Sodroski, H.-X. Liao, D. C. Montefiori, P. T. Hraber, B. T. Korber, B. F. Haynes, Strain-specific V3 and CD4 binding site autologous HIV-1 neutralizing antibodies select neutralization-resistant viruses. Cell Host Microbe 18, 354-362 (2015).
74. C. Moog, H. J. Fleury, I. Pellegrin, A. Kirn, A. M. Aubertin, Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. J. Virol. 71, 3734-3741 (1997).
75. K. J. Bar, M. C. Sneller, L. J. Harrison, J. S. Justement, E. T. Overton, M. E. Petrone, D. B. Salantes, C. A. Seamon, B. Scheinfeld, R. W. Kwan, G. H. Learn, M. A. Proschan, E. F. Kreider, J. Blazkova, M. Bardsley, E. W. Refsland, M. Messer, K. E. Clarridge, N. B. Tustin, P. J. Madden, K. Oden, S. J. O'Dell, B. Jarocki, A. R. Shiakolas, R. L. Tressler, N. A. Doria-Rose, R. T. Bailer, J. E. Ledgerwood, E. V. Capparelli, R. M. Lynch, B. S. Graham, S. Moir, R. A. Koup, J. R. Mascola, J. A. Hoxie, A. S. Fauci, P. Tebas, T.-W. Chun, Effect of HIV antibody VRC01 on viral rebound after treatment interruption. N. Engl. J. Med. 375, 2037-2050 (2016).
76. M. Caskey, F. Klein, J. C. C. Lorenzi, M. S. Seaman, A. P. West Jr., N. Buckley, G. Kremer, L. Nogueira, M. Braunschweig, J. F. Scheid, J. A. Horwitz, I. Shimeliovich, S. Ben-Avraham, M. Witmer-Pack, M. Platten, C. Lehmann, L. A. Burke, T. Hawthorne, R. J. Gorelick, B. D. Walker, T. Keler, R. M. Gulick, G. Fätkenheuer, S. J. Schlesinger, M. C. Nussenzweig, Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature 522, 487-491 (2015).
77. R. M. Lynch, E. Boritz, E. E. Coates, A. DeZure, P. Madden, P. Costner, M. E. Enama, S. Plummer, L. Holman, C. S. Hendel, I. Gordon, J. Casazza, M. Conan-Cibotti, S. A. Migueles, R. Tressler, R. T. Bailer, A. McDermott, S. Narpala, S. O'Dell, G. Wolf, J. D. Lifson, B. A. Freemire, R. J. Gorelick, J. P. Pandey, S. Mohan, N. Chomont, R. Fromentin, T.-W. Chun, A. S. Fauci, R. M. Schwartz, R. A. Koup, D. C. Douek, Z. Hu, E. Capparelli, B. S. Graham, J. R. Mascola, J. E. Ledgerwood; VRC 601 Study Team, Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Sci. Transl. Med. 7, 319ra206 (2015).
78. J. F. Scheid, J. A. Horwitz, Y. Bar-On, E. F. Kreider, C.-L. Lu, J. C. C. Lorenzi, A. Feldmann, M. Braunschweig, L. Nogueira, T. Oliveira, I. Shimeliovich, R. Patel, L. Burke, Y. Z. Cohen, S. Hadrigan, A. Settler, M. Witmer-Pack, A. P. West Jr., B. Juelg, T. Keler, T. Hawthorne, B. Zingman, R. M. Gulick, N. Pfeifer, G. H. Learn, M. S. Seaman, P. J. Bjorkman, F. Klein, S. J. Schlesinger, B. D. Walker, B. H. Hahn, M. C. Nussenzweig, HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption. Nature 535, 556-560 (2016).
79. A. Halper-Stromberg, C.-L. Lu, F. Klein, J. A. Horwitz, S. Bournazos, L. Nogueira, T. R. Eisenreich, C. Liu, A. Gazumyan, U. Schaefer, R. C. Furze, M. S. Seaman, R. Prinjha, A. Tarakhovsky, J. V. Ravetch, M. C. Nussenzweig, Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell 158, 989-999 (2014).
80. T. Schoofs, F. Klein, M. Braunschweig, E. F. Kreider, A. Feldmann, L. Nogueira, T. Oliveira, J. C. C. Lorenzi, E. H. Parrish, G. H. Learn, A. P. West Jr., P. J. Bjorkman, S. J. Schlesinger, M. S. Seaman, J. Czartoski, M. J. McElrath, N. Pfeifer, B. H. Hahn, M. Caskey, M. C. Nussenzweig, HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1. Science 352, 997-1001 (2016).
81. C.-L. Lu, D. K. Murakowski, S. Bournazos, T. Schoofs, D. Sarkar, A. Halper-Stromberg, J. A. Horwitz, L. Nogueira, J. Golijanin, A. Gazumyan, J. V. Ravetch, M. Caskey, A. K. Chakraborty, M. C. Nussenzweig, Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo. Science 352, 1001-1004 (2016).
82. The International HIV Contorllers Study, F. Pereyra, X. Jia, P. J. McLaren, A. Telenti, P. I. de Bakker, B. D. Walker, S. Ripke, C. J. Brumme, S. L. Pulit, M. Carrington, C. M. Kadie, J. M. Carlson, D. Heckerman, R. R. Graham, R. M. Plenge, S. G. Deeks, L. Gianniny, G. Crawford, J. Sullivan, E. Gonzalez, L. Davies, A. Camargo, J. M. Moore, N. Beattie, S. Gupta, A. Crenshaw, N. P. Burtt, C. Guiducci, N. Gupta, X. Gao, Y. Qi, Y. Yuki, A. Piechocka-Trocha, E. Cutrell, R. Rosenberg, K. L. Moss, P. Lemay, J. O'Leary, T. Schaefer, P. Verma, I. Toth, B. Block, B. Baker, A. Rothchild, J. Lian, J. Proudfoot, D. M. Alvino, S. Vine, M. M. Addo, T. M. Allen, M. Altfeld, M. R. Henn, S. Le Gall, H. Streeck, D. W. Haas, D. R. Kuritzkes, G. K. Robbins, R. W. Shafer, R. M. Gulick, C. M. Shikuma, R. Haubrich, S. Riddler, P. E. Sax, E. S. Daar, H. J. Ribaudo, B. Agan, S. Agarwal, R. L. Ahern, B. L. Allen, S. Altidor, E. L. Altschuler, S. Ambardar, K. Anastos, B. Anderson, V. Anderson, U. Andrady, D. Antoniskis, D. Bangsberg, D. Barbaro, W. Barrie, J. Bartczak, S. Barton, P. Basden, N. Basgoz, S. Bazner, N. C. Bellos, A. M. Benson, J. Berger, N. F. Bernard, A. M. Bernard, C. Birch, S. J. Bodner, R. K. Bolan, E. T. Boudreaux, M. Bradley, J. F. Braun, J. E. Brndjar, S. J. Brown, K. Brown, S. T. Brown, J. Burack, L. M. Bush, V. Cafaro, O. Campbell, J. Campbell, R. H. Carlson, J. K. Carmichael, K. K. Casey, C. Cavacuiti, G. Celestin, S. T. Chambers, N. Chez, L. M. Chirch, P. J. Cimoch, D. Cohen, L. E. Cohn, B. Conway, D. A. Cooper, B. Cornelson, D. T. Cox, M. V. Cristofano, G. Cuchural Jr., J. L. Czartoski, J. M. Dahman, J. S. Daly, B. T. Davis, K. Davis, S. M. Davod, E. DeJesus, C. A. Dietz, E. Dunham, M. E. Dunn, T. B. Ellerin, J. J. Eron, J. J. Fangman, C. E. Farel, H. Ferlazzo, S. Fidler, A. Fleenor-Ford, R. Frankel, K. A. Freedberg, N. K. French, J. D. Fuchs, J. D. Fuller, J. Gaberman, J. E. Gallant, R. T. Gandhi, E. Garcia, D. Garmon, J. C. Gathe Jr., C. R. Gaultier, W. Gebre, F. D. Gilman, I. Gilson, P. A. Goepfert, M. S. Gottlieb, C. Goulston, R. K. Groger, T. D. Gurley, S. Haber, R. Hardwicke, W. D. Hardy, P. R. Harrigan, T. N. Hawkins, S. Heath, F. M. Hecht, W. K. Henry, M. Hladek, R. P. Hoffman, J. M. Horton, R. K. Hsu, G. D. Huhn, P. Hunt, M. J. Hupert, M. L. Illeman, H. Jaeger, R. M. Jellinger, M. John, J. A. Johnson, K. L. Johnson, H. Johnson, K. Johnson, J. Joly, W. C. Jordan, C. A. Kauffman, H. Khanlou, R. K. Killian, A. Y. Kim, D. D. Kim, C. A. Kinder, J. T. Kirchner, L. Kogelman, E. M. Kojic, P. T. Korthuis, W. Kurisu, D. S. Kwon, M. LaMar, H. Lampiris, M. Lanzafame, M. M. Lederman, D. M. Lee, J. M. Lee, M. J. Lee, E. T. Lee, J. Lemoine, J. A. Levy, J. M. Llibre, M. A. Liguori, S. J. Little, A. Y. Liu, A. J. Lopez, M. R. Loutfy, D. Loy, D. Y. Mohammed, A. Man, M. K. Mansour, V. C. Marconi, M. Markowitz, R. Marques, J. N. Martin, H. L. Martin Jr., K. H. Mayer, M. J. McElrath, T. A. McGhee, B. H. McGovern, K. McGowan, D. McIntyre, G. X. McLeod, P. Menezes, G. Mesa, C. E. Metroka, D. Meyer-Olson, A. O. Miller, K. Montgomery, K. C. Mounzer, E. H. Nagami, I. Nagin, R. G. Nahass, M. O. Nelson, C. Nielsen, D. L. Norene, D. H. O'Connor, B. O. Ojikutu, J. Okulicz, O. O. Oladehin, E. C. Oldfield III, S. A. Olender, M. Ostrowski, W. F. Owen Jr., E. Pae, J. Parsonnet, A. M. Pavlatos, A. M. Perlmutter, M. N. Pierce, J. M. Pincus, L. Pisani, L. J. Price, L. Proia, R. C. Prokesch, H. C. Pujet, M. Ramgopal, A. Rathod, M. Rausch, J. Ravishankar, F. S. Rhame, C. S. Richards, D. D. Richman, B. Rodes, M. Rodriguez, R. C. Rose III, E. S. Rosenberg, D. Rosenthal, P. E. Ross, D. S. Rubin, E. Rumbaugh, L. Saenz, M. R. Salvaggio, W. C. Sanchez, V. M. Sanjana, S. Santiago, W. Schmidt, H. Schuitemaker, P. M. Sestak, P. Shalit, W. Shay, V. N. Shirvani, V. I. Silebi, J. M. Sizemore Jr., P. R. Skolnik, M. Sokol-Anderson, J. M. Sosman, P. Stabile, J. T. Stapleton, S. Starrett, F. Stein, H. J. Stellbrink, F. L. Sterman, V. E. Stone, D. R. Stone, G. Tambussi, R. A. Taplitz, E. M. Tedaldi, A. Telenti, W. Theisen, R. Torres, L. Tosiello, C. Tremblay, M. A. Tribble, P. D. Trinh, A. Tsao, P. Ueda, A. Vaccaro, E. Valadas, T. J. Vanig, I. Vecino, V. M. Vega, W. Veikley, B. H. Wade, C. Walworth, C. Wanidworanun, D. J. Ward, D. A. Warner, R. D. Weber, D. Webster, S. Weis, D. A. Wheeler, D. J. White, E. Wilkins, A. Winston, C. G. Wlodaver, A. van't Wout, D. P. Wright, O. O. Yang, D. L. Yurdin, B. W. Zabukovic, K. C. Zachary, B. Zeeman, M. Zhao, The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330, 1551-1557 (2010).
83. N. T. Freund, J. F. Scheid, H. Mouquet, M. C. Nussenzweig, Amplification of highly mutated human Ig lambda light chains from an HIV-1 infected patient. J. Immunol. Methods 418, 61-65 (2015).
84. T. Tiller, E. Meffre, S. Yurasov, M. Tsuiji, M. C. Nussenzweig, H. Wardemann, Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329, 112-124 (2008).
85. F. Klein, L. Nogueira, Y. Nishimura, G. Phad, A. P. West Jr., A. Halper-Stromberg, J. A. Horwitz, A. Gazumyan, C. Liu, T. R. Eisenreich, C. Lehmann, G. Fätkenheuer, C. Williams, M. Shingai, M. A. Martin, P. J. Bjorkman, M. S. Seaman, S. Zolla-Pazner, G. B. Karlsson Hedestam, M. C. Nussenzweig, Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants. J. Exp. Med. 211, 2361-2372 (2014).
86. M. Li, F. Gao, J. R. Mascola, L. Stamatatos, V. R. Polonis, M. Koutsoukos, G. Voss, P. Goepfert, P. Gilbert, K. M. Greene, M. Bilska, D. L. Kothe, J. F. Salazar-Gonzalez, X. Wei, J. M. Decker, B. H. Hahn, D. C. Montefiori, Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79, 10108-10125 (2005).
87. A. P. West Jr., L. Scharf, J. Horwitz, F. Klein, M. C. Nussenzweig, P. J. Bjorkman, Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues. Proc. Natl. Acad. Sci. U.S.A. 110, 10598-10603 (2013).
88. W. Kabsch, XDS. Acta Crystallogr. D Biol. Crsytallogr. 66, 125-132 (2010).
89. P. Emsley, K. Cowtan, Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crsytallogr. 60, 2126-2132 (2004).
90. G. Tang, L. Peng, P. R. Baldwin, D. S. Mann, W. Jiang, I. Rees, S. J. Ludtke, EMAN2: An extensible image processing suite for electron microscopy. J. Struct. Biol. 157, 38-46 (2007).
91. S. H. W. Scheres, RELION: Implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519-530 (2012).
92. R. Diskin, P. M. Marcovecchio, P. J. Bjorkman, Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity. Nat. Struct. Mol. Biol. 17, 608-613 (2010).
93. L. Scharf, H. Wang, H. Gao, S. Chen, A. W. McDowall, P. J. Bjorkman, Broadly neutralizing antibody 8ANC195 recognizes closed and open states of HIV-1 Env. Cell 162, 1379-1390 (2015).
94. S. H. W. Scheres, S. Chen, Prevention of overfitting in cryo-EM structure determination. Nat. Methods 9, 853-854 (2012).
95. J. R. Kremer, D. N. Mastronarde, J. R. McIntosh, Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 116, 71-76 (1996).
96. E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. Ferrin, UCSF Chimera-A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004).
97. R. L. Stanfield, A. Zemla, I. A. Wilson, B. Rupp, Antibody elbow angles are influenced by their light chain class. J. Mol. Biol. 357, 1566-1574 (2006).
98. M. N. Amin, J. S. McLellan, W. Huang, J. Orwenyo, D. R. Burton, W. C. Koff, P. D. Kwong, L.-X. Wang, Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies. Nat. Chem. Biol. 9, 521-526 (2013).
99. M. A. Larkin, G. Blackshields, N. P. Brown, R. Chenna, P. A. McGettigan, H. McWilliam, F. Valentin, I. M. Wallace, A. Wilm, R. Lopez, J. D. Thompson, T. J. Gibson, D. G. Higgins, Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948 (2007).
100. M. Kearse, R. Moir, A. Wilson, S. Stones-Havas, M. Cheung, S. Sturrock, S. Buxton, A. Cooper, S. Markowitz, C. Duran, T. Thierer, B. Ashton, P. Meintjes, A. Drummond, Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28, 1647-1649 (2012).
101. D. Darriba, G. L. Taboada, R. Doallo, D. Posada, jModelTest 2: More models, new heuristics and parallel computing. Nat. Methods 9, 772 (2012).
102. S. Guindon, J.-F. Dufayard, V. Lefort, M. Anisimova, W. Hordijk, O. Gascuel, New algorithms and methods to estimate maximum-likelihood phylogenies: Assessing the performance of PhyML 3.0. Syst. Biol. 59, 307-321 (2010).
103. P. B. Gilbert, A. J. Rossini, R. Shankarappa, Two-sample tests for comparing intra-individual genetic sequence diversity between populations. Biometrics 61, 106-117 (2005).
104. W. Deng, B. S. Maust, D. C. Nickle, G. H. Learn, Y. Liu, L. Heath, S. L. Kosakovsky Pond, J. I. Mullins, DIVEIN: A web server to analyze phylogenies, sequence divergence, diversity, and informative sites. Biotechniques 48, 405-408 (2010).